# SubjectWell

SubjectWell is an Asset Manager based in Austin, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Austin, United States
- **Region:** North America
- **Address:** Austin, TX, United States
- **Founded:** 2012
- **Assets under management:** Undisclosed
- **Website:** subjectwell.com
- **LinkedIn:** https://www.linkedin.com/company/subjectwell

## Regulatory record

- **Reports private funds:** No

## About

Subject is a patient recruitment firm based in Austin, United States, established in 2012. It provides risk-free patient recruitment services for clinical trials. The firm has secured $51.36 million in total funding.

## Sectors

- Digital Health
- Healthcare Services

## People

- Ivor Clarke — Chief Executive Officer

## Questions

### Who runs investment decisions and strategic direction at SubjectWell?

Ivor Clarke is the founder and Chief Executive Officer. As a venture-backed operating company, strategic decisions — including capital allocation and M&A — are approved by the board of directors, which includes representation from investors Chicago Pacific Founders and Windham Venture Partners.

### How does SubjectWell source and identify eligible clinical trial patients?

SubjectWell combines de-identified insurance claims and electronic health record data covering approximately 120 million Americans. Algorithms match patient profiles against trial inclusion and exclusion criteria for active studies. Patients are then reached through targeted multi-channel outreach and can review trial information before consenting to be connected with a site.

### What therapeutic areas does SubjectWell cover?

SubjectWell recruits patients across more than 50 disease areas. The firm has significant depth in cardiology, gastroenterology, CNS disorders, and rare diseases. Its June 2024 acquisition of Oligo Medic added rheumatology as a specific area of operational strength.

### Does SubjectWell conduct clinical trials or just recruit for them?

SubjectWell does not conduct clinical trials. It functions as a patient recruitment and engagement layer that pre-screens and connects potential participants with investigator sites and sponsor-led trials. The firm's double-opt-in marketplace means patients consent both to learn about a trial and to have their information shared with the relevant site.

## Related profiles

- [Aktana](https://altss.com/profile/aktana)
- [Accurate Group](https://altss.com/profile/accurate-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/subjectwell

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology